Senolytic Agent Navitoclax Inhibits Angiotensin II-Induced Heart Failure in Mice

Jia, KN; Dai, Y; Liu, AO; Li, X; Wu, LQ; Lu, L; Bao, YY; Jin, Q

Jin, Q (corresponding author), Shanghai Ruijin Hosp, Dept Cardiol, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020; 76 (4): 452

Abstract

Navitoclax, which is a type of senolytic drug, selectively eliminates senescent cells. This study aimed to evaluate the therapeutic potential of navit......

Full Text Link